Canaparo Roberto, Nordmark Anna, Finnström Niklas, Lundgren Stefan, Seidegård Janeric, Jeppsson Bengt, Edwards Robert J, Boobis Alan R, Rane Anders
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden.
Basic Clin Pharmacol Toxicol. 2007 Apr;100(4):240-8. doi: 10.1111/j.1742-7843.2006.00023.x.
Our objective was to investigate the expression of different cytochromes P450 3A (CYP3A4, CYP3A5, and CYP3A7) and P-glycoprotein (ABCB1) genes along the human large intestine in paired tumour and normal samples. Real-time reverse transcriptase-polymerase chain reaction was used to measure CYP3A4-, CYP3A5-, CYP3A7- and ABCB1-specific mRNA expression, and Western blot analysis was used to measure membrane protein levels of CYP3A4/7, CYP3A5 and P-glycoprotein. Levels of mRNA and membrane protein fractions in the large intestine were compared with those of normal human liver. The mRNA expressions of CYP3A4, CYP3A5, CYP3A7 and ABCB1 in the large intestine were found to be highly variable, but overall the levels were significantly lower than those measured in liver (P < 0.0001, P < 0.001, P < 0.0001 and P < 0.01, respectively). At the membrane protein level, CYP3A4/7 was detected in all large intestine samples examined and the levels were substantially higher than those of the liver (P < 0.01). Although expression of CYP3A5 was detected in all large intestine samples, in most the levels were too low to allow quantification. P-glycoprotein was readily detected at levels slightly higher than those of liver (P < 0.05). Comparison between paired samples of normal and tumour in large intestine showed no significant differences in either the mRNA or membrane protein levels of these genes. In conclusion, this work suggests a potential role of the large intestine in the absorption and metabolism of xenobiotics and nutrients and no difference in the CYP3A and P-glycoprotein membrane protein fractions and mRNA expression between normal and tumour tissues.
我们的目的是研究在配对的肿瘤和正常样本中,不同细胞色素P450 3A(CYP3A4、CYP3A5和CYP3A7)和P-糖蛋白(ABCB1)基因在人类大肠中的表达情况。采用实时逆转录-聚合酶链反应来测量CYP3A4、CYP3A5、CYP3A7和ABCB1特异性mRNA表达,并用蛋白质免疫印迹分析来测量CYP3A4/7、CYP3A5和P-糖蛋白的膜蛋白水平。将大肠中mRNA和膜蛋白组分的水平与正常人类肝脏的水平进行比较。发现大肠中CYP3A4、CYP3A5、CYP3A7和ABCB1的mRNA表达高度可变,但总体水平显著低于在肝脏中测得的水平(分别为P < 0.0001、P < 0.001、P < 0.0001和P < 0.01)。在膜蛋白水平上,在所检测的所有大肠样本中均检测到CYP3A4/7,其水平显著高于肝脏(P < 0.01)。虽然在所有大肠样本中均检测到CYP3A5的表达,但在大多数样本中其水平过低无法进行定量。P-糖蛋白很容易被检测到,其水平略高于肝脏(P < 0.05)。大肠中正常和肿瘤配对样本之间的比较显示,这些基因的mRNA或膜蛋白水平均无显著差异。总之,这项研究表明大肠在异生素和营养物质的吸收与代谢中可能发挥作用,并且正常组织和肿瘤组织之间CYP3A和P-糖蛋白的膜蛋白组分及mRNA表达没有差异。